The Implantable Infusion Pumps Market Size is valued at USD16.24 Billion in 2023 and is predicted to reach USD 23.96 Billion by the year 2031 at a 5.15 % CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
The global implantable infusion pumps market is segmented on the basis of application and region. Based on the application, the market is divided into malignant pain management, cancer treatment, non-malignant pain management, and spasticity treatment. Based on region, the market is studied across North America, Asia-Pacific, Europe, Latin America and Middle East & Africa. Among that, North America held the largest share of the market, followed by Europe. On the other hand, Asia-Pacific is expected to dominate the market during the analysis of the forecast period.
In Nov 2022, Medtronic introduced the first and only infusion set for insulin pumps in the world, which has increased wear duration by seven days in the United States. Typically, an insulin pump supplied insulin to the body via tubing known as the infusion set, which required replacement every two to three days
| Report Attribute | Specifications |
| Market Size Value In 2023 | USD 16.24 Billion |
| Revenue Forecast In 2031 | USD 23.96 Billion |
| Growth Rate CAGR | CAGR of 5.15 % from 2024 to 2031 |
| Quantitative Units | Representation of revenue in US$ Billion, Volume (Unit), and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Application, By Product Type, By End-User |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Codman & Shurtleff, Inc (Johnson & Johnson), I-Flow Corp/Hylard Health, Flowobix Medical, Inc., Medtronic, Tricumed Medizintechnik GmbH., Debiotech SA, Eksigent Technologies LLC, InBrain Pharma SAS, Intarcia Therapeutics Inc., and others |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Implantable Infusion Pumps Market Snapshot
Chapter 4. Global Implantable Infusion Pumps Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type & Market Share, 2019-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type:
5.2.1. Piston Type Infusion Pumps
5.2.2. Creeping Type Infusion Pumps
5.2.3. Enteral Pump
5.2.4. Elastomeric Pump
5.2.5. Insulin Pump
5.2.6. Syringe Pump
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2019-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application:
6.2.1. Cancer Treatment
6.2.2. Pediatrics/Neonatology
6.2.3. Gastroenterology
6.2.4. Hematology
6.2.5. Diabetes
6.2.6. Spasticity treatment
6.2.7. Others
Chapter 7. Market Segmentation 3: By End-User Estimates & Trend Analysis
7.1. By End-User & Market Share, 2019-2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End-User:
7.2.1. Hospitals
7.2.2. Ambulatory Surgical Centers
7.2.3. Specialty Clinics
Chapter 8. Implantable Infusion Pumps Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031
8.1.2. North America Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By Product Type, 2024-2031
8.1.3. North America Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By End-User, 2024-2031
8.1.4. North America Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe Implantable Infusion Pumps Market revenue (US$ Million) By Application, 2024-2031
8.2.2. Europe Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By Product Type, 2024-2031
8.2.3. Europe Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By End-User, 2024-2031
8.2.4. Europe Implantable Infusion Pumps Market revenue (US$ Million) by country, 2024-2031
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Implantable Infusion Pumps Market revenue (US$ Million) By Application, 2024-2031
8.3.2. Asia Pacific Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By Product Type, 2024-2031
8.3.3. Asia Pacific Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By End-User, 2024-2031
8.3.4. Asia Pacific Implantable Infusion Pumps Market revenue (US$ Million) by country, 2024-2031
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Implantable Infusion Pumps Market revenue (US$ Million) By Application, 2024-2031
8.4.2. Latin America Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By Product Type, 2024-2031
8.4.3. Latin America Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By End-User, 2024-2031
8.4.4. Latin America Implantable Infusion Pumps Market revenue (US$ Million) by country, (US$ Million) 2024-2031
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. Middle East & Africa
8.5.1. Middle East & Africa Implantable Infusion Pumps Market revenue (US$ Million) By Application, (US$ Million) 2024-2031
8.5.2. Middle East & Africa Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By Product Type, 2024-2031
8.5.3. Middle East & Africa Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By End-User, 2024-2031
8.5.4. Middle East & Africa Implantable Infusion Pumps Market revenue (US$ Million) by country, (US$ Million) 2024-2031
8.5.4.1. South Africa
8.5.4.2. GCC Countries
8.5.4.3. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Codman & Shurtleff, Inc (Johnson & Johnson)
9.2.2. I-Flow Corp/Hylard Health
9.2.3. Flowobix Medical, Inc.
9.2.4. Medtronic
9.2.5. Tricumed Medizintechnik GmbH.
9.2.6. Debiotech SA
9.2.7. Eksigent Technologies LLC
9.2.8. InBrain Pharma SAS
9.2.9. Intarcia Therapeutics Inc
9.2.10. Other Prominent Players
Global Implantable Infusion Pumps Market by Product Type
Global Implantable Infusion Pumps Market by Application
Global Implantable Infusion Pumps Market by End-User
Global Implantable Infusion Pumps Market Based on Region
Europe Implantable Infusion Pumps Market Outlook by Country
North America Implantable Infusion Pumps Market Outlook by Country
Asia Pacific Implantable Infusion Pumps Market Outlook by Country
Latin America Implantable Infusion Pumps Market Outlook by Country
Middle East & Africa Implantable Infusion Pumps Market Outlook by Country